DR-TB pacientebis mier samkurnalo reJimebis
Sesruleba
“samSabaToba”
29.06.10
cira Caxaia, TamTa komaxiZe
mizani
 axali
da warsulSi namkurnalebi pacientebis mier samkurnalo reJimebis Sesrulebis
Sefaseba ganyofilebebisa da Tveebis mixedviT
 preparatebis
mixedviT
 dozis
 im
arasrulyofilad miRebis daxasiaTeba gamotovebuli dozebisa da dReebis
arasrulad miRebis sixSiris gansazRvra
preparatebis gamovlena, romelTa arasruli doziT miReba xdeba upiratesad
mizani
 samkurnalo
 stacionarul
reJimebis arasrulyofilad Sesrulebis mizezebis gansazRvra
da ambulatoriul pirobebSi samkurnalo reJimebis Sesrulebis Sedareba
kavSiris dadgena preparatebis arasrul miRebasa da DST profilis
cvlilebas Soris
 asocirebuli
kavSiris dadgena samkurnalo reJimis Sesrulebasa da mkurnalobis
gamosavals Soris
 asocirebuli
meTodologia
wlis ianvarSi, TebervalSi, martsa da aprilSi gawerili DR-TB pacientebis
monacemebi Segrovda da damuSavda tfdec-is I, III da V Terapiuli
ganyofilebebidan (maisis monacemebi Tavad ganyofilebebma daamuSaves)
 2010
 monacemebi
Segrovda pacientTa monacemebi Segrovda pacientTa mkurnalobis
monitoringis formis safuZvelze;
Seqmnili kiTxvaris daxmarebiT monacemebi damuSavda Epiinfo-s programiT
 specialurad
kiTxvari



samkurnalo reJimis Sesruleba srulyofilad CaiTvala, Tu Tvis ganmavlobaSi arcerTi
preparati arcerTxel ar iyo gamotovebuli
Tvis ganmavlobaSi erTi dozis gamotovebac ki arasrulyofil samkurnalo reJimad
CaiTvala
arasrulyofili samkurnalo reJimi daiyo:
 dozebis mixedviT – 1, 2, 3 da yvela preparatis gamotoveba

dReebis mixedviT – 1-2, 3-9, 10 da meti dRis gamotoveba
DR-T B
PDR-TB
N
%
4
4,3%
80
87,0%
8
8,7%
92
100,0%
MDR-TB
XDR-TB
sul
MDR-TB SemTxvevebis ganawileba ganyofilebebis mixedviT
axali da warsulSi I da II rigis TB preparatebiT namkurnalebi pacientebis sixSire
SemTxveva
N
%
axali
33
35.9%
warsulSi namkurnalebi
59
64.1%
sul
92
100.0%
warsulSi namkurnalebi
N
%
I
37
62.7%
II
22
37.3%
sul
59
100.0%
axali da warsulSi namkurnalebi SemTxvevebis ganawileba
ganyofilebebis mixedviT
axali da warsulSi namkurnalebi pacientebis mier samkurnalo reJimis Sesruleba
(ianvari)
100
10.2
90
80
47.6
70
srulyofilad (ianvari)
60
50
89.8
40
30
52.4
20
10
0
axali
warsulSi namk.
arasrulyofilad (ianvari)
axali da warsulSi namkurnalebi pacientebis mier samkurnalo reJimis Sesruleba
(Tebervali)
100
25
90
80
56.5
70
srulyofilad (Tebervali)
60
arasrulyofilad (Tebervali)
50
75
40
30
43.5
20
10
0
axali
warsulSi namk.
axali da warsulSi namkurnalebi pacientebis mier samkurnalo reJimis Sesruleba
(marti)
100
26.9
90
80
65
70
srulyofilad (marti)
60
arasrulyofilad (marti)
50
73.1
40
30
35
20
10
0
axali
warsulSi namk.
axali da warsulSi namkurnalebi pacientebis mier samkurnalo reJimis Sesruleba
(aprili)
100
90
0
22.2
80
70
srulyofilad (aprili)
60
50
40
100
77.8
30
20
10
0
axali
warsulSi namk.
arasrulyofilad (aprili)
samkurnalo reJimis Sesrulebis dinamika Tveebis mixedviT
100.0%
88.9%
90.0%
80.0%
78.6%
70.0%
63.5%
56.5%
60.0%
50.0%
43.5%
20.0%
21.4%
11.1%
10.0%
0.0%
arasrulyofilad
36.5%
40.0%
30.0%
srulyofilad
ianvari
Tebervali
marti
aprili
samkurnalo reJimis Sesruleba Tveebis mixedviT
samkurnalo reJimis
Sesruleba
N (%)
ianvari
srulad
N (%)
Tebervali
marti
aprili
23 (36.5%)
20 (43.5%)
15 (21.4%)
2 (11.1%)
arasrulad
55 (78.6%)
40 (63.5%)
26 (56.5%)
16 (88.9%)
sul
70 (100%)
63 (100%)
46 (100%)
18 (100%)
samkurnalo reJimis Sesruleba ganyofilebebis mixedviT
(ianvari)
100
11.8
18.5
90
30.8
80
70
60
ianvari-srulyofilad
50
ianvari-arasrulyofilad
88.2
81.5
40
69.2
30
20
10
0
I
III
V
samkurnalo reJimis Sesruleba ganyofilebebis mixedviT
(Tebervali)
100
13.3
90
36.4
80
50
70
60
Tebervali-srulyofilad
50
Tebervali-arasrulyofilad
86.7
40
63.6
30
50
20
10
0
I
III
V
samkurnalo reJimis Sesruleba ganyofilebebis mixedviT (marti)
100
21.4
90
41.2
80
66.7
70
60
marti-srulyofilad
50
marti-arasrulyofilad
78.6
40
58.8
30
33.3
20
10
0
I
III
V
samkurnalo reJimis Sesruleba ganyofilebebis mixedviT
(aprili)
100
11.1
90
0
16.7
80
70
aprili-srulyofilad
60
50
88.9
40
100
83.3
30
20
10
0
I
III
V
aprili-arasrulyofilad
yvela preparatis gamotoveba
erTipreparatis gamotoveba
ori preparatis gamotoveba
sami preparatis gamotoveba
samze meti, magram arayvela preparatis gamotoveba
PAS-is gamotoveba Tveebis mixedviT
30.0%
27.8%
25.0%
20.0%
15.0%
20.0%
20.6%
18.6%
19.6%
17.5%
16.7%
15.2%
12.9%
10->10
1-2 dRe
12.7%
3-9 dRe
10.0%
8.7%
5.6%
5.0%
0.0%
ianvari
Tebervali
marti
aprili
Pto-is gamotoveba Tveebis mixedviT
14.0%
12.7%
12.0%
10.0%
8.7%
8.0%
6.0%
7.1%7.1%
5.7%
10->10
6.5%
6.3%
5.6%5.6%
4.3%
4.0%
3.2%
2.0%
0.0%
0.0%
ianvari
Tebervali
marti
aprili
1-2dRe
3-9dRe
daskvna

axal SemTxvevebTan SedarebiT warsulSi namkurnalebi pacientebi samkurnalo reJims
gacilebiT ufro xSirad arRveven

gacilebiT xSiria preparatebis arasrulyofilad miReba

reJimebis arasrulad Sesrulebis SemTxvevebSi sWarbobs 1, 2, an 3 preparatis 1-2 da 3-9
dRis ganmavlobaSi gamotovebis sixSire

Tveebis mixedviT samkurnalo reJimebis Sesruleba gansxvavebuli da arastabiluria

rogorc mosalodneli iyo upiratesad xdeba PAS-is da Pto-is dozebis da dReebis mixedviT
gamotoveba
preparatebis srulyofilad da arasrulyofilad miRebis sixSire ganyofilebebis mixedviT (maisi, 2010)
70%
60%
58%
57%
60%
50%
42%
40%
43%
40%
srulyofili
arasrulyofili
30%
20%
10%
0%
I
III
V
preparatebis xarjva (I Terapiuli gany.)
90%
89%
86%
90%
81%
86%
77%
80%
70%
84%
65%
60%
50%
miRebuli
gamotovebuli
40%
35%
30%
23%
19%
20%
14%
11%
16%
14%
10%
10%
0%
R
E
Z
Cm
Lfx
Pto
PAS
Cs
preparatebis xarjva (III Terapiuli gany.)
100%
93%
90%
88%
86%
88%
88%
90%
88%
87%
86%
81%
80%
68%
70%
60%
50%
gamotovebuli
40%
32%
30%
19%
20%
14%
12%
12%
12%
14%
12%
13%
10%
7%
10%
0%
E
Z
Cm
Lfx
Mfx
Pto
Cs
PAS
Amx/Clv
Clr
Cfz
preparatebis xarjva (III Terapiuli gany.)
100%
93%
91%
86%
90%
87%
88%
79%
80%
78%
75%
78%
70%
60%
miRebuli
50%
gamotovebuli
40%
30%
21%
20%
10%
14%
7%
13%
9%
22%
25%
22%
12%
0%
Cm
Lfx
Mfx
Pto
Cs
PAS
Amx/Clv
Clr
Cfz
Cm-is gamotovebis mizezebis sixSire
(I Terapia)
Cm
83%
90%
80%
70%
60%
50%
40%
30%
20%
15%
2%
10%
0%
ar iyo
gv. Mov
sxva miz.
PAS-is gamotovebis mizezebis sixSire
(III Terapia)
83%
90%
80%
70%
60%
50%
40%
30%
20%
15%
2%
10%
0%
ar iyo
gv. Mov
sxva miz.
preparatebis gamotovebis mizezebis sixSire
(V Terapia)
70%
64%65%
60%
50%
40%
36%
36%
32%
29%
25%
21%
30%
24%
30%
Cfz
11%
0%
6% 5%
4%
ar iyo
6%
4%
2%
gv.mov.
Tan.daav
SeC
Amx/Clv
Clr
20%
10%
PAS
sxva
gmadlobT yuradRebisaTvis